The benefits and costs of newer drugs: evidence from the 1996 Medical Expenditure Panel Survey
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2001
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
8147 |
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | 17, [8] S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023589852 | ||
| 003 | DE-604 | ||
| 005 | 20091109 | ||
| 007 | t | ||
| 008 | 010518s2001 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)46487546 | ||
| 035 | |a (DE-599)BVBBV023589852 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1 | |
| 100 | 1 | |a Lichtenberg, Frank R. |d 1951- |e Verfasser |0 (DE-588)12863717X |4 aut | |
| 245 | 1 | 0 | |a The benefits and costs of newer drugs |b evidence from the 1996 Medical Expenditure Panel Survey |c Frank R. Lichtenberg |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2001 | |
| 300 | |a 17, [8] S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 8147 | |
| 650 | 4 | |a Drugs |x Research |z United States | |
| 650 | 4 | |a Pharmaceutical industry |x Research |z United States | |
| 650 | 4 | |a Prescription pricing |z United States | |
| 651 | 4 | |a USA | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 8147 |w (DE-604)BV002801238 |9 8147 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w8147.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016905182 | ||
Datensatz im Suchindex
| _version_ | 1804138245255069696 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Lichtenberg, Frank R. 1951- |
| author_GND | (DE-588)12863717X |
| author_facet | Lichtenberg, Frank R. 1951- |
| author_role | aut |
| author_sort | Lichtenberg, Frank R. 1951- |
| author_variant | f r l fr frl |
| building | Verbundindex |
| bvnumber | BV023589852 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)46487546 (DE-599)BVBBV023589852 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01391nam a2200361zcb4500</leader><controlfield tag="001">BV023589852</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20091109 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010518s2001 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)46487546</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023589852</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lichtenberg, Frank R.</subfield><subfield code="d">1951-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)12863717X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The benefits and costs of newer drugs</subfield><subfield code="b">evidence from the 1996 Medical Expenditure Panel Survey</subfield><subfield code="c">Frank R. Lichtenberg</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">17, [8] S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">8147</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription pricing</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">8147</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">8147</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w8147.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016905182</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023589852 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:25Z |
| indexdate | 2024-07-09T21:25:07Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016905182 |
| oclc_num | 46487546 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 17, [8] S. graph. Darst. |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Lichtenberg, Frank R. 1951- Verfasser (DE-588)12863717X aut The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey Frank R. Lichtenberg Cambridge, Mass. National Bureau of Economic Research 2001 17, [8] S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 8147 Drugs Research United States Pharmaceutical industry Research United States Prescription pricing United States USA Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 8147 (DE-604)BV002801238 8147 http://papers.nber.org/papers/w8147.pdf kostenfrei Volltext |
| spellingShingle | Lichtenberg, Frank R. 1951- The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Drugs Research United States Pharmaceutical industry Research United States Prescription pricing United States |
| title | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey |
| title_auth | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey |
| title_exact_search | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey |
| title_exact_search_txtP | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey |
| title_full | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey Frank R. Lichtenberg |
| title_fullStr | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey Frank R. Lichtenberg |
| title_full_unstemmed | The benefits and costs of newer drugs evidence from the 1996 Medical Expenditure Panel Survey Frank R. Lichtenberg |
| title_short | The benefits and costs of newer drugs |
| title_sort | the benefits and costs of newer drugs evidence from the 1996 medical expenditure panel survey |
| title_sub | evidence from the 1996 Medical Expenditure Panel Survey |
| topic | Drugs Research United States Pharmaceutical industry Research United States Prescription pricing United States |
| topic_facet | Drugs Research United States Pharmaceutical industry Research United States Prescription pricing United States USA |
| url | http://papers.nber.org/papers/w8147.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT lichtenbergfrankr thebenefitsandcostsofnewerdrugsevidencefromthe1996medicalexpenditurepanelsurvey |